Poly Medicure Share Price
Small Cap | Pharmaceuticals and health care | NSE: POLYMED | BSE: 531768
₹2,574.00 -14.30 (-0.55 %)
Last Updated: 30 Apr 2025 03:56 PM
Overview
Open (₹) 2,588.30
High (₹) 2,594.90
Low (₹) 2,530.20
Prev. Close (₹) 2,588.30
Volume 69,680
VWAP (₹) 2,397.35
ROCE (%) 23.42
Industry P/E 76.37
TTM P/E 82.77
P/B Ratio 16.80
Market Cap (₹) Cr.26,081.24
Dividend Yield (%)0.12
EPS (₹) 26.90
ROE17.56%
Sales Growth (%) 23.36
Profit Growth (%)44.19
Day Range
2,594.902,594.90
52 Week Range
1,565.003,350.00
Historical Returns
Returns (6M)
-17.73 %
Returns (1Y)
56.65 %
Returns (3Y)
190.08 %
Returns (5Y)
1078.84 %
Returns (6M)
-17.73 %
Returns (1Y)
56.65 %
Returns (3Y)
190.08 %
Returns (5Y)
1078.84 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (44.08%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 44.08% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Increasing Revenue every Quarter for the past 4 Quarters
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- High CCI indicates strong upward momentum.
- Positive ROC (9) indicates upward momentum.
- Strong trend indicated by ADX above 25.
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
RSI 37.17
MFI 75.77
ATR 109.74
Commodity Channel Index 161.47
ROC125 2.10
ROC21 8.10
Williams %R -10.09
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 2,458.26 | 2,523.03 | 2,601.06 | 2,380.23 | 2,315.46 | 2,237.43 | 2,172.66 |
Week Ago | 2,080.16 | 2,123.43 | 2,165.01 | 2,038.58 | 1,995.31 | 1,953.73 | 1,910.46 |
Month Ago | 2,238.30 | 2,264.10 | 2,293.25 | 2,209.15 | 2,183.35 | 2,154.20 | 2,128.40 |
EMA & SMA
2574.00
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 2163.57
9 Day 2184.38
10 Day 2172.37
12 Day 2181.25
14 Day 2181.36
20 Day 2205.53
26 Day 2216.42
50 Day 2231.31
100 Day 2439.82
200 Day 2366.64
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
LIGHTHOUSE INDIA III EQUITY INVESTORS LIMITED | bulk | Sell | 21st Jun, 2024 | ₹1,950.03 | 22,76,269 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
17th Aug, 2023 | RISHI BAID | Disposal | ₹1,473.93 | 24,950 | NSE |
14th Aug, 2023 | RISHI BAID | Disposal | ₹1,472.70 | 99,264 | NSE |
1st Apr, 2022 | RISHI BAID | Disposal | ₹943.63 | 30,000 | NSE |
29th Mar, 2022 | RISHI BAID | Disposal | ₹847.67 | 60,000 | NSE |
28th Mar, 2022 | RISHI BAID | Disposal | ₹846.94 | 10,000 | NSE |
1st Jul, 2021 | VCB TRADING LLP | Disposal | ₹995.00 | 1,00,000 | NSE |
11th Mar, 2020 | J.K. SANCHETI OSWAL | Acquisition | ₹289.01 | 450 | NSE |
11th Mar, 2020 | NIDHI OSWAL DAUGHTER OF CFO | Disposal | ₹309.43 | 210 | NSE |
11th Mar, 2020 | J.K. SANCHETI OSWAL | Disposal | ₹309.47 | 900 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
17th May, 2024 | Rs.3.0000 per share(60%)Final Dividend | 19th Sept, 2024 | 1st Jan, 1970 |
9th May, 2023 | Rs.3.0000 per share(60%)Final Dividend | 21st Sept, 2023 | 1st Jan, 1970 |
24th May, 2022 | Rs.2.5000 per share(50%)Final Dividend | 16th Sept, 2022 | 1st Jan, 1970 |
Announcements
Date | Source | Detail |
---|---|---|
29th Apr, 2025 | BSE India | Poly Medicure Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 ,inter alia, to consider and approve The Company has informed the Exchange about the Board Meeting scheduled to be held on 06th May, 2025 for the purpose of approving the Audited Financial Results (Standalone & Consolidated) for the quarter and year ended 31st March, 2025 and also Final Dividend for the Financial Year ended 31st March, 2025. |
24th Apr, 2025 | NSE India | Poly Medicure Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
14th Apr, 2025 | NSE India | Poly Medicure Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 |
31st Mar, 2025 | NSE India | Poly Medicure Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
31st Mar, 2025 | NSE India | POLY MEDICURE LIMITED has informed the Exchange about Closure of Trading Window |
11th Mar, 2025 | NSE India | Poly Medicure Limited has informed the Exchange about Receiving the Medical Device Regulation (MDR) Certification in Europe for 54 Products |
11th Mar, 2025 | BSE India | Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith is a press release issued by the Company on the captioned subject, the content of which is self explanatory. |
13th Feb, 2025 | NSE India | Poly Medicure Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 |
13th Feb, 2025 | NSE India | Monitoring Agency Report for the Quarter ended 31st December, 2024. |
13th Feb, 2025 | BSE India | Statement of Deviation(s) and Variation(s) for the quarter ended 31st December, 2024 |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Audited Results & Final Dividend | -- | 29th Apr, 2025 | 6th May, 2025 |
Quarterly Results & Others | To consider other business matters. | 29th Jan, 2025 | 3rd Feb, 2025 |
Quarterly Results & ESOP | -- | 22nd Oct, 2024 | 28th Oct, 2024 |
Quarterly Results | -- | 19th Jul, 2024 | 22nd Jul, 2024 |
Others | Inter alia, to consider and finalize the terms and condition and approve the modes of fund raising. | 17th Jul, 2024 | 29th Jun, 2024 |
Audited Results & Final Dividend | -- | 7th May, 2024 | 17th May, 2024 |
Others | Inter alia, to consider a) Business Plan for Financial Year 2024-25. b) To consider and evaluate a proposal for raising of funds, in one or more tranches, through permissible mode(s). | 5th Mar, 2024 | 8th Mar, 2024 |
Quarterly Results | -- | 20th Jan, 2024 | 31st Jan, 2024 |
Quarterly Results | -- | 26th Oct, 2023 | 4th Nov, 2023 |
Quarterly Results | -- | 27th Jul, 2023 | 7th Aug, 2023 |
Share Holding Pattern
Owner Name | Mar, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
---|---|---|---|---|---|
Promoter Group | 62.44% | 62.44% | 53.16% | 53.33% | 44.76% |
Foreign Institutions + | 11.46% | 12.33% | 14.1% | 16.33% | 14.13% |
Domestic Institutions + | 11.96% | 11.66% | 5.46% | 3.38% | 2.99% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 14.14% | 13.57% | 27.28% | 26.96% | 38.12% |
Others | 0% | 0% | 0% | 0% | 0% |
About Poly Medicure
Poly Medicure is a Public Limited Listed company incorporated on 30/03/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L40300DL1995PLC066923 and registration number is 066923. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 1307.25 Cr. and Equity Capital is Rs. 47.99 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
1995
Managing Director
Mr. Himanshu Baid
NSE Symbol
POLYMED
Poly Medicure Management
Name | Designation |
---|---|
Mr. Devendra Raj Mehta | Chairman |
Mr. Himanshu Baid | Managing Director |
Mr. Rishi Baid | Joint Managing Director |
Mr. Jugal Kishore Baid | Non Executive Director |
Mrs. Mukulika Baid | Non Executive Director |
Mr. Alessandro Balboni | Non Executive Director |
Dr. Shailendra Raj Mehta | Ind. Non-Executive Director |
Dr. Ambrish Mithal | Ind. Non-Executive Director |
Dr. Sandeep Bhargava | Ind. Non-Executive Director |
Mr. Vimal Bhandari | Ind. Non-Executive Director |
Mr. Amit Khosla | Ind. Non-Executive Director |
Ms. Sonal Mattoo | Ind. Non-Executive Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Poly Medicure | ₹26,081.24 | ₹2,574.00 ₹2,588.30(-0.55%) | ₹1,565.000 - ₹3,350.000 |
Tarsons Products | ₹1,925.00 | ₹361.80 ₹371.25(-2.55%) | ₹282.000 - ₹543.800 |
Borosil Scientific | ₹1,163.96 | ₹130.88 ₹130.65(0.18%) | ₹109.800 - ₹229.800 |
Vasa Denticity | ₹1,037.61 | ₹624.25 ₹634.00(-1.54%) | ₹480.000 - ₹840.000 |
Prevest Denpro | ₹566.54 | ₹472.00 ₹473.40(-0.30%) | ₹351.000 - ₹686.000 |
FAQs on Poly Medicure
What is the share price of Poly Medicure?
The share price of Poly Medicure on 30th Apr, 2025 is ₹ 2,574.00.
What is 52W high and 52W low share price of Poly Medicure?
The highest and lowest 52W share prices of Poly Medicure are ₹ 3350.000 and ₹ 1565.000
What is the market cap of Poly Medicure?
The market capitalization of Poly Medicure as of 30th Apr, 2025 is ₹ 26,081.24 Crores
What is the P/E ratio of Poly Medicure?
The current P/E ratio of Poly Medicure as of 30th Apr, 2025 is 76.37
What is the PB ratio of Poly Medicure?
The PB ratio of Poly Medicure as of 30th Apr, 2025 is 16.80
Top Gainers
₹78.00
₹65.00 (0.20%)
₹121.03
₹100.86 (0.20%)
₹13.15
₹11.00 (0.20%)
₹1.88
₹1.57 (0.20%)
Top Losers
₹107.95
₹123.00 (-0.12%)
₹0.50
₹0.56 (-0.11%)
₹24.55
₹28.11 (-0.13%)
₹3.34
₹3.80 (-0.12%)
Market Indices
Sensex
₹80,242.24
₹80,288.38 (0.00%)